UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

Biostar Pharmaceuticals, Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

090678103
(CUSIP Number)

03/25/2011
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:

* Rule 13d-1(b)

x Rule 13d-1(c)

* Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 090678103

1
NAMES OF REPORTING PERSONS:
Andrew Barron Worden



2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION

United States of America


NUMBER OF

5
SOLE VOTING POWER
253,431
SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER

0
EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
253,431

WITH

8
SHARED DISPOSITIVE POWER

498,933
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 752,364

10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.7%

12
TYPE OF REPORTING PERSON

IN



 CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
Barron Partners

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER
121,359
SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER

0
EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
 121,359

WITH

8
SHARED DISPOSITIVE POWER
0

9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 121,359


10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.4%

12
TYPE OF REPORTING PERSON

PN








CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
XWRT2 LP

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER
19,502
SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER

0
EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER

19,502
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
19,502


10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.1%

12
TYPE OF REPORTING PERSON

PN


CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
SBMT2 LP

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER
23,238
SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER

0
EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER
23,238
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

23,238
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.1%
12
TYPE OF REPORTING PERSON
PN




CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
Godfrey2468 LP

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER

 25,671

SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER
0

EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER

0
WITH

8
SHARED DISPOSITIVE POWER
25,671
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 25,671

10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.1%
12
TYPE OF REPORTING PERSON

PN



CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
RossPlan LP


2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER
 88,383


SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER
0

EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
88,383
WITH

8
SHARED DISPOSITIVE POWER
 0


9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 88,383
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.3%

12
TYPE OF REPORTING PERSON

PN



CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
Tibero2 LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware


NUMBER OF

5
SOLE VOTING POWER
 12,136


SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER

0
EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
 0

WITH

8
SHARED DISPOSITIVE POWER
 12,136


9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 12,136

10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%

12
TYPE OF REPORTING PERSON

PN



CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
Kaufman2 LP

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER
 40,288


SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER
0

EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER
 40,288

9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 40,288


10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.1%
12
TYPE OF REPORTING PERSON

PN


 CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
ABJ Investment Fund LP

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware



NUMBER OF

5
SOLE VOTING POWER

 28,107



SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER

0
EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER

 28,107


9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 28,107


10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.1%
12
TYPE OF REPORTING PERSON

PN



 CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
Golden1177 LP

2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware


NUMBER OF

5
SOLE VOTING POWER

 336,535


SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER
0

EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER
 336,535


9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 336,535

10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

1.2%
12
TYPE OF REPORTING PERSON
PN






1
NAMES OF REPORTING PERSONS:
Olga Filippova
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Russian Federation



NUMBER OF

5
SOLE VOTING POWER
 1,456
SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER
0

EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER
 1,456
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 1,456
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.0%
12
TYPE OF REPORTING PERSON
IN

CUSIP No. 090678103




CUSIP No. 090678103
1
NAMES OF REPORTING PERSONS:
2DanesRunnin LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) x
(b)
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware



NUMBER OF

5
SOLE VOTING POWER
 12,000

SHARES
BENEFICIALL
Y
OWNED BY
6
SHARED VOTING POWER
0

EACH
REPORTING
PERSON
7
SOLE DISPOSITIVE POWER
0
WITH

8
SHARED DISPOSITIVE POWER
 12,000

9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 12,000

10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 *


11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

0.0%
12
TYPE OF REPORTING PERSON
PN






Item 1.
(a) Name of Issuer:
Biostar Pharmaceuticals, Inc.

(b) Address of Issuer's Principal Executive Offices:
No. 588 Shiji Avenue Xiangyang City, Shaanxi Province
People's Republic of China 712046

Item 2.
(a) Name of Person(s) Filing:
Andrew Barron Worden, citizen of USA
Barron Partners LP, a DE limited partnership
Golden1177 LP, a DE limited partnership
XWRT2 LP, a DE limited partnership
SBMT2 LP, a DE limited partnership
Godfrey2468 LP, a DE limited partnership
RossPlan LP, a DE limited partnership
Tibero2 LP, a DE limited partnership
Kaufman2 LP, a DE limited partnership
ABJ Investment Fund LP, a DE limited partnership
Olga Filippova, citizen of Russian Federation
2DanesRunnin LP, a DE limited partnership

 (b) Address of Principal Business Office, or, if None, Residence:
Andrew Barron Worden 730 Fifth Avenue, 26th Floor, New York, NY
10019.
Barron Partners LP, 730 Fifth Avenue, 26th Floor, New York, NY 10019.
Golden1177 LP, #500-1177 West Hastings Street, Vancouver BC V6E 2K3
Canada
XWRT2 LP, 131 Laurel Grove Avenue Kentfield, CA 94904
SBMT2 LP, 104 S. Pecos Street Midland, TX 79701
Godfrey2468 LP, 279 Saugatuck Avenue Westport, CT 06880
RossPlan LP, 50 Central Park South, Unit 34/35 New York, NY 10019
Tibero2 LP, 29 Evergreen Way Wokingham, Berkshire RG41 4BX United
Kingdom
Kaufman2 LP, 127 W. 69th Street New York, Ny 10023
ABJ Investment Fund LP, #500-117 West Hastings Street, Vancouver BC
V6E 2K3 Canada
Olga Filippova, 3 Havelock Terrace, Sandymount, Dublin 4, Ireland
2DanesRunnin LP, 2565 Tanglewood Blvd., Pottsboro Texas 75076

 (c) Citizenship or Place of Organization:
Please see response to part (a) of this Item 2.


 (d) Title of Class of Securities:

 Common Stock

 (e) CUSIP Number:
 090678103
Item 3. If This Statement is Filed Pursuant to Rule 240.13d-1(b), or
240.13d-2(b) or (c), check whether the person filing is a:

N/A
Item 4. Ownership.

(a) Amount Beneficially Owned:
 752,364

(b) Percentage of Class:

 The responses of the Reporting Persons to Row 11 on pages 2 - 13
are incorporated herein by reference.

 (c) Number of Shares to which such person has:

 (i) sole power to vote or direct the vote
 (ii) shared power to vote or direct the vote
 (iii) sole power to dispose or to direct the disposition of
 (iv) shared power to dispose or to direct the disposition of

 The responses of the Reporting Persons to Rows 5 through 8 on
pages 2 - 13 are incorporated herein by reference.


Item 5. Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following. [X]



Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
N/A

Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company or Control Person:

N/A



Item 8. Identification and Classification of Members of the Group:

 See item 2 above

Item 9. Notice of Dissolution of Group:

 Not applicable.

Item 10. Certifications

 By signing below, I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and
are not held for the purpose or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.

 SIGNATURE

 After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
Dated: April 4, 2011


Andrew B. Worden
By: /s/ Andrew B. Worden

Barron Partners LP
By: Barron Capital Advisors LLC, its general partner
By: /s/ Andrew B. Worden
Name: Andrew B. Worden
Title: Managing Member

RossPlan LP
By: /s/ Andrew B. Worden
Name: Andrew B. Worden
Title: General Partner
Golden1177 LP
By: Golden Properties Ltd., its general partner
By: /s/ Alexander Lau
Name: Alexander Lau
Title: Manager

XWRT2 LP
By: /s/ Joseph Abrams
Name: Joseph Abrams
Title: General Partner

SMBT2 LP
By: Carlton Beal Family Trust FBO Spencer Beal, its general partner
By: /s/ Spence Beal
Name: Spence Beal
Title: Trustee

Godfrey2468 LP
By: /s/ Peter Godfrey
Name: Peter Godfrey
Title: General Partner

Tibero2 LP
By: /s/ Tim Robinson
Name: Tim Robinson
Title: General Partner

Kaufman2 LP
By: Dash.com Inc, its General Partner
By: /s/ Daniel Kaufman
Name: Daniel Kaufman
Title: President

ABJ Investment Fund LP
By: /s/ Sandra Lau
Name: Sandra Lau
Title: General Partner

Olga Filippova
By: /s/ Olga Filippova

2DanesRunnin LP
By: Higher Ground Investments LP its General Partner
By: The Canyons Climbing LLC, its General Partner
By: /s/ Robert A. Kaiser
Name: Robert A. Kaiser
Title: Managing Member

2

Biostar Pharmaceuticals (CE) (USOTC:BSPM)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Biostar Pharmaceuticals (CE).
Biostar Pharmaceuticals (CE) (USOTC:BSPM)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Biostar Pharmaceuticals (CE).